Home » Topics » BioWorld Science

BioWorld Science
RSS

Targeted cancer therapy leads to twist of cell fate

Oct. 16, 2018

Astellas Cathespin S inhibitors prolong graft survival in a mouse cardiac transplant model

Oct. 16, 2018

Neurons can switch transmitter allegiance in vivo

Oct. 16, 2018

Messenger RNA can treat porphyria

Oct. 16, 2018

Australian TGA clears Peptilogics to begin phase I study of PLG-0206

Oct. 15, 2018

FDA approves Yutiq for chronic noninfectious posterior segment uveitis

Oct. 15, 2018

Sanofi initiates first-in-human study of SAR-440234 in ALL, AML and MDS

Oct. 15, 2018

CheckMate-331 study of Opdivo in relapsed SCLC does not meet primary endpoint

Oct. 15, 2018

NIH grant supports work on Feldan Shuttle to deliver CRISPR nucleases to airway epithelia

Oct. 15, 2018

Targovax reports DFS data from phase I/II trial of TG-01 in resected pancreatic cancer

Oct. 15, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...